TEL AVIV, April 21 (Reuters) - Shares in generic drugmakers Teva Pharmaceutical Industries and Mylan jumped in pre-market trade in New York on a report from Bloomberg that Teva could make a public unsolicited offer for Mylan as soon as Tuesday.
A spokesman for Teva, the world's largest maker of generic drugs, said the company does not comment on rumours or reports.
20:47 Visa's adjusted profit jumps 27 percent29
19:18 U.S. Says Canada Lumber Duty Is Part of Trade Enforcer Drive19
03:27 Ahead of NAFTA talks, U.S. sets 20 percent duties on Canadian softwood lumber19
21:12 Number of U.S. bank branches to shrink 20 percent in five years: real estate report19